Browse by Title

Type here to filter the list

T
Thales: A unified framework for clinical-scale QSP modeling
Favorite

Ryan Suderman, PhD (he/him/his) – Simulations Plus, Inc. ### 2360730###Speaker###Associate Director/Sr. Principal Scientist###Simulations Plus, Inc.###
Speaker: Ryan Suderman, PhD (he/him/his) – Simulations Plus, Inc.
### he/him/his
The best of both worlds? Integration of QSP and PMx modeling in support of MIDD in oncology
Favorite

Blerta Shtylla, PhD (she/her/hers) – Pharmacometrics & Systems Pharmacology, Pfizer Research and Development, La Jolla, CA ### 2360738###Speaker###Research Fellow###Pharmacometrics & Systems Pharmacology, Pfizer Research and Development, La Jolla, CA###
Speaker: Blerta Shtylla, PhD (she/her/hers) – Pharmacometrics & Systems Pharmacology, Pfizer Research and Development, La Jolla, CA
### she/her/hers
The current clinical needs and gaps for precision medicine of special populations
Favorite

Dongyang Liu, PhD (he/him/his) – Drug Clinical Trial Center, Peking University Third Hospital ### 2379985###Speaker###Deputy Director###Drug Clinical Trial Center, Peking University Third Hospital###
Speaker: Dongyang Liu, PhD (he/him/his) – Drug Clinical Trial Center, Peking University Third Hospital
### he/him/his
The flawed assumption of proportional hazards in oncology studies - What are the alternatives?
Favorite

Andrew C. Hooker, PhD, ISOP member – Uppsala University ### 2360680###Speaker###Professor of Pharmacometrics###Uppsala University###
Speaker: Andrew C. Hooker, PhD, ISOP member – Uppsala University
###
The Future of Pharmacokinetics: Digital Twins and OoC in Harmony
Favorite

Wilhelmus E.A. De Witte, PhD – ESQlabs ### 2343519###Speaker###Lead Large Molecule Platform - Principal Scientist###ESQlabs###
Speaker: Wilhelmus E.A. De Witte, PhD – ESQlabs
###
The Practical Bayesian: How Bayesian Methodology is Incorporated into Clinical Drug Development
Favorite

Jiawei Zhou, PhD (she/her/hers) – Pfizer, Inc. ### 2360697###Chair###Manager, Pharmacometrics & Systems Pharmacology###Pfizer, Inc.###
Chair: Jiawei Zhou, PhD (she/her/hers) – Pfizer, Inc.
### she/her/hers @@@ Luke Fostvedt, PhD – Pfizer, Inc. ### 2360696###Chair###Director, Pharmacometrics & Systems Pharmacology###Pfizer, Inc.###
Chair: Luke Fostvedt, PhD – Pfizer, Inc.
### @@@ Timothy Waterhouse, PhD (he/him/his) – Metrum Research Group ### 2360698###Speaker###Principal Scientist II###Metrum Research Group###
Speaker: Timothy Waterhouse, PhD (he/him/his) – Metrum Research Group
### he/him/his @@@ Ralph Smith, PhD – North Carolina State University ### 2360699###Speaker###Distinguished University Professor, Professor of Mathematics###North Carolina State University###
Speaker: Ralph Smith, PhD – North Carolina State University
### @@@ Nastya Kassir, PharmD, PhD, FCP (she/her/hers) – Genentech ### 2343528###Speaker###Senior Director & Distinguished Scientist###Genentech###
Speaker: Nastya Kassir, PharmD, PhD, FCP (she/her/hers) – Genentech
### she/her/hers
The Regulatory Landscape of Quantitative Pharmacology for New Therapeutic Modalities at the FDA
Favorite

Joy C. Hsu, PhD – Genentech ### 2360676###Moderator###Director, Clinical Pharmacology and Pharmacometrics###Genentech###
Moderator: Joy C. Hsu, PhD – Genentech
### @@@ Sojeong Yi, PhD – FDA ### 2363740###Speaker###Clinical Pharmacology Reviewer###FDA###
Speaker: Sojeong Yi, PhD – FDA
### @@@ Hao Zhu, PhD – ISoP ### 2360688###Panelist###ISoP Board Member###ISoP###
Panelist: Hao Zhu, PhD – ISoP
###
The Use of Quantitative Systems Pharmacology-based Digital Twins to Support Drug Development in Rare Diseases
Favorite

Susana Zaph, PhD (she/her/hers) – Sanofi ### 2360669###Speaker###Senior Director & Head of Translational Disease Modeling - US###Sanofi###
Speaker: Susana Zaph, PhD (she/her/hers) – Sanofi
### she/her/hers
Tools for streamlining PMx Dataset Review: Data Visualization, Exploration, and Quality Assurance
Favorite

Xiaobin Li, M.S – GSK ### 2407936###Speaker###Programming Director, CPMS Programming and Business Excellence###GSK###
Speaker: Xiaobin Li, M.S – GSK
###
Total-Body PET Kinetic Modeling and Its Potential Applications to Drug Development and Evaluation
Favorite

Guobao Wang, PhD (he/him/his) – University of California, Davis ### 2360746###Speaker###Professor of Radiology###University of California, Davis###
Speaker: Guobao Wang, PhD (he/him/his) – University of California, Davis
### he/him/his
Towards Generalizability of Neural ODEs in predictive applications in pharmacometrics
Favorite

Sean Hayes, PhD – Merck Research Laboratories ### 2360751###Speaker###Associate Director, Data Science###Merck Research Laboratories###
Speaker: Sean Hayes, PhD – Merck Research Laboratories
###
Trainee Tutorial: Minimal PBPK Modeling: Tutorial and Applications
Favorite

Sean McCann (he/him/his) – University of North Carolina ### 2370821###Co-Chair###Graduate Research Assistant###University of North Carolina###
Co-Chair: Sean McCann (he/him/his) – University of North Carolina
### he/him/his @@@ Yuhan Long, BS, BSChE (he/him/his) – University of Minnesota ### 2384750###Co-Chair###Graduate Student###University of Minnesota###
Co-Chair: Yuhan Long, BS, BSChE (he/him/his) – University of Minnesota
### he/him/his @@@ Yanguang Cao, PhD (he/him/his) – University of North Carolina at Chapel Hill ### 2360726###Speaker###Associate Professor###University of North Carolina at Chapel Hill###
Speaker: Yanguang Cao, PhD (he/him/his) – University of North Carolina at Chapel Hill
### he/him/his @@@ Xiaonan Li, PhD (she/her/hers) – Takeda Pharmaceuticals ### 2408459###Speaker###Sr. Clinical Pharmacologist###Takeda Pharmaceuticals###
Speaker: Xiaonan Li, PhD (she/her/hers) – Takeda Pharmaceuticals
### she/her/hers @@@ Dongfen Yuan, PhD – Janssen Research & Development ### 2408458###Speaker###Associate Director###Janssen Research & Development###
Speaker: Dongfen Yuan, PhD – Janssen Research & Development
###
Trainee Tutorial: Q&A
Favorite
Transforming Healthcare with Large Language Models: Opportunities and challenges
Favorite

Joga Gobburu, PhD MBA (he/him/his) – University of Maryland ### 2380204###Speaker###Professor###University of Maryland###
Speaker: Joga Gobburu, PhD MBA (he/him/his) – University of Maryland
### he/him/his
Tutorial: Model-Based Meta-Analysis: towards more precisely predicted clinical scenarios
Favorite

Monica Simeoni, PhD – Clinical Pharmacology Modelling and Simulation, Precision Medicine, GSK ### 2360711###Chair and Speaker###Director###Clinical Pharmacology Modelling and Simulation, Precision Medicine, GSK###
Chair and Speaker: Monica Simeoni, PhD – Clinical Pharmacology Modelling and Simulation, Precision Medicine, GSK
### @@@ Phyllis Chan, PhD – Modeling & Simulation, Clinical Pharmacology, Genentech ### 2360712###Chair###Distinguished Scientist###Modeling & Simulation, Clinical Pharmacology, Genentech###
Chair: Phyllis Chan, PhD – Modeling & Simulation, Clinical Pharmacology, Genentech
### @@@ Matthew L. Zierhut, PhD MBA (he/him/his) – Certara Drug Development Solutions ### 2360713###Speaker###VP###Certara Drug Development Solutions###
Speaker: Matthew L. Zierhut, PhD MBA (he/him/his) – Certara Drug Development Solutions
### he/him/his @@@ Rana JREICH, PhD – Clinical Modeling, Clinical Modeling & Evidence Integration, Sanofi ### 2360714###Speaker###Associate Director###Clinical Modeling, Clinical Modeling & Evidence Integration, Sanofi###
Speaker: Rana JREICH, PhD – Clinical Modeling, Clinical Modeling & Evidence Integration, Sanofi
### @@@ Elyes Dahmane, PhD – FDA ### 2360754###Speaker###Pharmacometrics Reviewer###FDA###
Speaker: Elyes Dahmane, PhD – FDA
### @@@ Joseph Chen, PharmD – Genentech ### 2453821###Speaker###Senior Principal Scientist###Genentech###
Speaker: Joseph Chen, PharmD – Genentech
###
Tutorial: Using Past Models to Bridge to Open Models and Open Science using nlmixr2
Favorite

Matthew L. Fidler, M.Stat., PhD (he/him/his) – Novartis ### 2360655###Chair###Director###Novartis###
Chair: Matthew L. Fidler, M.Stat., PhD (he/him/his) – Novartis
### he/him/his @@@ William S Denney, Ph.D. (he/him/his) – Human Predictions ### 2360656###Speaker and Panelist###Chief Scientist###Human Predictions###
Speaker and Panelist: William S Denney, Ph.D. (he/him/his) – Human Predictions
### he/him/his @@@ Mirjam Trame, Ph.D (she/her/hers) – Certara ### 2360657###Speaker and Panelist###Vice President Pharmacometrics###Certara###
Speaker and Panelist: Mirjam Trame, Ph.D (she/her/hers) – Certara
### she/her/hers @@@ Justin J. Wilkins, PhD (he/him/his) – Occams ### 2360658###Speaker and Panelist###Owner and Senior Consultant at Occams, Fellow and past president of ISoP###Occams###
Speaker and Panelist: Justin J. Wilkins, PhD (he/him/his) – Occams
### he/him/his